Skip to main content

Assessing Rett Symptoms with Cutting Edge Biosensors and Invisible Technology

April 26, 2021

A key aspect of effective clinical trials is the ability to objectively and accurately measure Rett syndrome symptoms. The current measurement tools which are questionnaires are subjective and rely on others interpreting a Rett individual's symptoms. Learn how RSRT is using technology to capture symptomatic data directly from individuals with Rett. Dr. David Lieberman, director of the Rett clinic at Boston Children's Hospital speaks to RSRT's Dr. Jana von Hehn about the biosensors and "invisibles" that are being tested.


More Resources

RSRT Clinical Initiatives

Rett News About Biosensors


Take Action

It’s not a question of “if” we’ll find cures, but “when”. You’re one click away from bringing that day closer.